Duman TT, Ucar Y, Turkoglu ES, Atak Tel BM, Bilgin S, Aktas G. Effects of sodium glucose co-transporter-2 inhibitors and glucagon like peptide-1 receptor agonists in diabetic metabolic dysfunction-associated steatotic liver disease management. World J Diabetes 2026; 17(7): 119285 [DOI: 10.4239/wjd.119285]
Xiaojiao Jia, Qiang Lu, Changshun Xie. TyG-related indices as reliable markers for identifying MASLD-associated metabolic phenotypes in type 2 diabetes. Scientific Reports 2026; 16(1)doi: 10.1038/s41598-026-72461-7